![Kenneth Mobeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 775 475 $ al 31/08/2026
Kenneth S.
Mobeck is Chief Financial Officer at EDAP TMS SA since 2024.
Mr. Mobeck was Vice President-Finance & Investor Relations at Accuray, Inc. from 2019 to 2022.
Mr. Mobeck completed undergraduate and MBA degrees at Leavey School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EDAP TMS SA 0,48 % | 14/08/2026 | 181.610 ( 0,48 % ) | 775 475 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDAP TMS S.A. | Director Financiero/CFO | 01/01/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| ACCURAY INCORPORATED | Contacto de Relaciones con Inversores | 01/12/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
EDAP TMS SA
 EDAP TMS SA Medical SpecialtiesHealth Technology Develops, produces and markets minimally invasive medical devices for urological diseases | Health Technology |
Accuray, Inc.
 Accuray, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Leavey School of Business
 Leavey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
